16.05.2014 • News
generics
07.04.2014 • News
Swedish Drugmaker Meda Spurns Mylan Approach
02.04.2014 • Topics • Technology
GDUFA’s Impact on the API Industry – an Update
21.02.2014 • News
Actavis to Buy Forest Labs for $25 billion
11.02.2014 • News
German Generics Producers Charge Discrimination
27.01.2014 • News
Fourth Ranbaxy Generics Plant Hit by FDA Ban
31.10.2013 • Topics • Technology
Double Risk with an Upgrade
30.10.2013 • Topics • Technology
Sourcing from India and China
08.10.2013 • News
GlaxoSmithKline India Hit By Drop In Bulk Orders
11.09.2013 • Topics • Technology
Saltigo: 'Working Proactively With Trends'
Adaptability — A lot has happened in the world of custom manufacturing since Saltigo was carved out of Lanxess' fine chemicals business in 2006.
10.09.2013 • Topics • Technology
Enzymes as a Catalytic All Rounder
06.08.2013 • Topics • Technology
GDUFA’s Impact on the API Industry
23.05.2013 • News
Pfizer to Spin Off Zoetis Stake to Shareholders
14.05.2013 • News
Sanofi Fined in Plavix Generics Dispute
Porsche Consulting
FDA Smart
Codexis
ARC Advisory Group GmbH & Co KG
Arthur D. Little
CMS Advisors GmbH & Co. KG
Deutsche Post DHL
Camelot Management Consultants AG
F. Hoffmann-La Roche Ltd
Saltigo GmbH
SchüllerConsulting
Camelot Management Consultants AG
Fitch Ratings
Enigma Marketing Research
GlobalData
Thomson Reuters